Made-In-Singapore Active Pharmaceutical Ingredients get easier access to EU
Singapore, Nov. 19 -- Singapore, through the Health Sciences Authority (HSA), has been recognised by the European Commission for its regulatory framework for active pharmaceutical ingredients (APIs), affirming that its quality oversight of APIs produced in Singapore provides public health protection equivalent to that required in the European Union (EU).
The Commission has adopted a decision that Singapore's standards and controls on Good Manufacturing Practice (GMP) in Singapore for APIs, which are the active substances responsible for the intended therapeutic effects of medicines, is equivalent to that in the EU.
With this recognition, made-in-Singapore APIs for use in human medicines can now be exported to the EU through simpler and ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.